Insider Selling: Phreesia (NYSE:PHR) General Counsel Sells 3,995 Shares of Stock

by · The Markets Daily

Phreesia, Inc. (NYSE:PHR – Get Free Report) General Counsel Allison Hoffman sold 3,995 shares of the firm’s stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $65,358.20. Following the completion of the transaction, the general counsel owned 169,661 shares of the company’s stock, valued at $2,775,653.96. The trade was a 2.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Phreesia Stock Performance

PHR stock traded down $0.63 during midday trading on Tuesday, reaching $15.76. 888,246 shares of the company were exchanged, compared to its average volume of 1,011,187. Phreesia, Inc. has a one year low of $15.41 and a one year high of $32.76. The business has a 50-day moving average price of $18.24 and a two-hundred day moving average price of $23.18. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The firm has a market capitalization of $950.23 million, a price-to-earnings ratio of -157.59 and a beta of 0.61.

Phreesia (NYSE:PHR – Get Free Report) last issued its quarterly earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.11. The business had revenue of $120.33 million during the quarter, compared to analysts’ expectations of $119.98 million. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.25) earnings per share. Equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current year.

Analysts Set New Price Targets

PHR has been the topic of a number of recent analyst reports. Barclays dropped their price target on shares of Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 16th. Needham & Company LLC restated a “buy” rating and issued a $35.00 target price on shares of Phreesia in a report on Monday, December 8th. BMO Capital Markets started coverage on Phreesia in a research note on Thursday, November 13th. They issued an “outperform” rating and a $32.00 price objective for the company. Citigroup lowered their price objective on Phreesia from $29.00 to $25.00 and set a “buy” rating on the stock in a research note on Friday, January 9th. Finally, KeyCorp dropped their price objective on Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $30.06.

Check Out Our Latest Research Report on Phreesia

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Squarepoint Ops LLC boosted its position in shares of Phreesia by 243.6% in the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after purchasing an additional 71,553 shares during the period. Arcadia Investment Management Corp MI raised its position in shares of Phreesia by 22.3% during the 2nd quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock valued at $3,229,000 after buying an additional 20,700 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after acquiring an additional 3,000 shares during the last quarter. Acadian Asset Management LLC grew its stake in shares of Phreesia by 61.6% during the second quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock valued at $10,357,000 after buying an additional 138,877 shares during the last quarter. Finally, Boston Partners increased its stake in Phreesia by 165.1% in the 2nd quarter. Boston Partners now owns 130,060 shares of the company’s stock worth $3,702,000 after buying an additional 81,006 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

(Get Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Further Reading